RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Marian Melish to Tumor Necrosis Factor-alpha

Back to Details
This is a "connection" page, showing publications Marian Melish has written about Tumor Necrosis Factor-alpha.
Marian Melish
Connection Strength
0.219
Tumor Necrosis Factor-alpha
  1. Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr. 2005 May; 146(5):662-7.
    View in: PubMed
    Score: 0.219
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support